4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0001140361-16-088447
Chief Financial Officer acquired 1,289 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Goeltz II Robert C. · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-11-30 | Grant or award : show line 1 in the form | +1,289 | $9.10 | $11,723 | 7,289 | D |
Loading xslF345X03/doc1.xml…